Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACZ885 in Abdominal Aortic Aneurysm
NCT02007252Phase 2Terminated
- Sponsor
- Novartis
- Start
- Dec 2013
- Primary completion
- Oct 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of canakinumab in abdominal aortic aneurysm (AAA), sponsored by Novartis. Started Dec 2013; status: terminated.
02
Drugs
canakinumab
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT02007252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007252.